TY - JOUR
T1 - Future perspectives in melanoma research. Meeting report from the "Melanoma Research
T2 - A bridge Naples-USA. Naples, December 6th-7 th2010"
AU - Ascierto, Paolo A.
AU - De Maio, Eleonora
AU - Bertuzzi, Stefano
AU - Palmieri, Giuseppe
AU - Halaban, Ruth
AU - Hendrix, Mary
AU - Kashani-sabet, Mohamed
AU - Ferrone, Soldano
AU - Wang, Ena
AU - Cochran, Alistair
AU - Rivoltini, Licia
AU - Lee, Peter P.
AU - Fox, Bernard A.
AU - Kirkwood, John M.
AU - Ullmann, Claudio D.
AU - Lehmann, Frederic F.
AU - Sznol, Mario
AU - Schwartzentruber, Douglas J.
AU - Maio, Michele
AU - Flaherty, Keith
AU - Galon, Jerome
AU - Ribas, Antoni
AU - Yang, James
AU - Stroncek, David F.
AU - Mozzillo, Nicola
AU - Marincola, Franco M.
N1 - Funding Information:
This work was supported by the Italian Ministry of Health “Progetto Ricerca Corrente Istituto Nazionale Tumori Pascale M2/11 Approccio multidisciplinare dalla ricerca alla cura del melanoma” and by Fondazione Melanoma Onlus. Authors would like to thank authors who have provided Tables originally published in Cancer Vaccines, Second Edition (2011) edited by Adrian Bot, Mihail Obrocea, and Franco Marincola; available from Informa Healthcare http://informahealthcare.com/.
PY - 2011/3/26
Y1 - 2011/3/26
N2 - Progress in understanding the molecular basis of melanoma has made possible the identification of molecular targets with important implications in clinical practice. In fact, new therapeutic approaches are emerging from basic science and it will be important to implement their rapid translation into clinical practice by active clinical investigation. The first meeting of Melanoma Research: a bridge Naples-USA, organized by Paolo A. Ascierto (INT, Naples, Italy) and Francesco Marincola (NIH, Bethesda, USA) took place in Naples, on 6-7 December 2010. This international congress gathered more than 30 international and Italian faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive discussion across Institutions belonging to Government, Academy and Pharmaceutical Industry, in order to stimulate new approaches in basic, translational and clinical research. Four topics of discussion were identified: New pathways in Melanoma, Biomarkers, Clinical Trials and New Molecules and Strategies.
AB - Progress in understanding the molecular basis of melanoma has made possible the identification of molecular targets with important implications in clinical practice. In fact, new therapeutic approaches are emerging from basic science and it will be important to implement their rapid translation into clinical practice by active clinical investigation. The first meeting of Melanoma Research: a bridge Naples-USA, organized by Paolo A. Ascierto (INT, Naples, Italy) and Francesco Marincola (NIH, Bethesda, USA) took place in Naples, on 6-7 December 2010. This international congress gathered more than 30 international and Italian faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive discussion across Institutions belonging to Government, Academy and Pharmaceutical Industry, in order to stimulate new approaches in basic, translational and clinical research. Four topics of discussion were identified: New pathways in Melanoma, Biomarkers, Clinical Trials and New Molecules and Strategies.
UR - http://www.scopus.com/inward/record.url?scp=79953098794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953098794&partnerID=8YFLogxK
U2 - 10.1186/1479-5876-9-32
DO - 10.1186/1479-5876-9-32
M3 - Review article
C2 - 21439082
AN - SCOPUS:79953098794
SN - 1479-5876
VL - 9
JO - Journal of Translational Medicine
JF - Journal of Translational Medicine
M1 - 32
ER -